COMMUNIQUÉ DE PRESSE publié le 28/08/2025 à 08:37, il y a 1 année 2 mois Fuller, Smith & Turner PLC: Share Buyback Programme Fuller, Smith & Turner PLC has announced a new share buyback program with Numis Securities Limited to repurchase up to 1 million 'A' Ordinary Shares in the Company, emphasizing long-term sustainable growth and shareholder value London Stock Exchange Share Buyback Program Numis Securities Limited Fuller Smith Turner PLC Capital Allocation
BRÈVE publiée le 28/08/2025 à 08:26, il y a 1 année 2 mois Fuller, Smith & Turner PLC Extends Share Buyback Programme Voting Rights Share Buyback Treasury Shares Numis Securities Fuller, Smith & Turner
BRÈVE publiée le 28/08/2025 à 08:26, il y a 1 année 2 mois Fuller, Smith & Turner PLC prolonge son programme de rachat d'actions Actions Propres Rachat D'actions Droit De Vote Numis Securities Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 28/08/2025 à 08:21, il y a 1 année 2 mois Fuller, Smith & Turner PLC: Transaction in own securities – conclusion and extension of buyback programme Fuller, Smith & Turner PLC concludes and extends buyback programme, repurchasing one million 'A' Ordinary Shares for £5.65 million, with Numis Securities Limited. Company to hold shares in Treasury Treasury Fuller, Smith & Turner PLC Numis Securities Limited 'A' Ordinary Shares Buyback Programme
BRÈVE publiée le 26/08/2025 à 18:32, il y a 1 année 2 mois Fuller, Smith & Turner PLC Executes Share Buyback Voting Rights Share Buyback Treasury Shares Market Regulation Fuller's PLC
BRÈVE publiée le 26/08/2025 à 18:32, il y a 1 année 2 mois Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Droit De Vote Régulation Du Marché PLC De Fuller
COMMUNIQUÉ DE PRESSE publié le 26/08/2025 à 18:27, il y a 1 année 2 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 1,293 of its own shares at an average price of 568.00 GBp per share as part of its share buyback programme London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited Purchase Announcement
BRÈVE publiée le 22/08/2025 à 19:19, il y a 1 année 2 mois Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Share Buyback Market Abuse Regulation Treasury Shares Fuller, Smith & Turner
BRÈVE publiée le 22/08/2025 à 19:19, il y a 1 année 2 mois Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Bourse De Londres Réglementation Sur Les Abus De Marché Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 22/08/2025 à 19:14, il y a 1 année 2 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 1,651 ‘A’ Ordinary Shares as part of its share buyback program, with highest price at 562.00 GBp and lowest at 560.00 GBp London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Purchase Details
Publié le 04/11/2026 à 18:00, il y a 10 heures The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 10 heures L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 10 heures 16 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 50 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 5 heures Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 45 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 55 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:55, il y a 5 minutes AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Publié le 05/11/2026 à 03:10, il y a 50 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 58 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 8 heures 19 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 35 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting